Federal Register / Vol. 72, No. 176 / Wednesday, September 12, 2007 / Notices 52155 

Drive, MSC 7936, Bethesda, MD 20892–

7936, or call non-toll-free number 301–

435–1284 or E-mail your request, 

including your address to: 

AvilessantaL@NHLBI.NIH.GOV. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

Dated: September 7, 2007. 

Mike Lauer, 

Director, Division of Prevention and 

Population Sciences, NHLBI, National 

Institutes of Health. 

Dated: September 7, 2007. 

Suzanne Freeman, 

Chief, FOIA, NHLBI, National Institutes of 

Health. 

[FR Doc. E7–17986 Filed 9–11–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; The Cardiovascular Health 

Study (CHS) 

SUMMARY: In compliance with the 

requirement of section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Heart, Lung, and Blood 

Institute (NHLBI), the National 

Institutes of Health (NIH) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

PROPOSED COLLECTION: Title: The 

Cardiovascular Health Study. Type of 

Information Request: Reinstatement. 

(OMB No. 0925–0334). Need and Use of 

Information Collection: This study 

quantifies associations between 

conventional and hypothetical risk 

factors and coronary heart disease 

(CHD) and stroke in people age 65 years 

and older. The primary objectives 

include quantifying associations of risk 

factors with subclinical disease; 

characterizing the natural history of 

CHD and stroke; and identifying factors 

associated with clinical course. The 

findings provide important information 

on cardiovascular disease in an older 

U.S. population and lead to early 

treatment of risk factors associated with 

disease and identification of factors that 

may be important in disease prevention. 

OBM clearance is being sought for data 

collection activities at only one of the 

four CHS field centers (the Pittsburgh 

field center), which are expected to end 

on May 31, 2008. Other data collection 

efforts in the CHS cohort are supported 

by various non-contract funding 

sources. Frequency of response: twice a 

year (participants) or once per 

cardiovascular disease event (proxies 

and physicians); Affected public: 

Individuals. Types of Respondents: 

Individuals recruited for CHS and their 

selected proxies and physicians. The 

annual reporting burden is as follows: 

Estimated Number of Respondents: 556; 

Estimated Number of Responses per 

respondent: 1.2; and Estimated Total 

Annual Burden Hours Requested: 289. 

The annualized cost to respondents is 

estimated at: $14,450. 

There are no capital, operating, or 

maintenance costs to report. 

Type of respondents Estimated number 

of respondents 

Estimated number 

of responses per 

respondent* 

Average burden 

hours per 

response 

Estimated total annual burden hours 

requested 

Participants ............................................................................ 346 1.2 0.5 208 

Physicians .............................................................................. 70 1.2 0.1 8 

Participant proxies ................................................................. 121 1.2 0.5 73 

Total ................................................................................ 537 1.2 0.45 289 

*Total for 3 years. 

REQUEST FOR COMMENTS: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

data collection plans and instruments, 

contact Dr. Jean Olson, Epidemiology 

Branch, Division of Prevention and 

Population Sciences, NHLBI, NIH, II 

Rockledge Centre, 6701 Rockledge 

Drive, Suite 10018, MSC # 7936, 

Bethesda, MD 20892–7936, or call 301–

435–0397 (non-toll-free number), or email your request, including your 

address to: OlsonJ@nhlbi.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: August 29, 2007. 

Mike Lauer, 

Director, Division of Prevention and 

Population Sciences, NHLBI, National 

Institutes of Health. 

Suzanne Freeman, 

Chief, FOIA, NHLBI, National Institutes of 

Health. 

[FR Doc. E7–18012 Filed 9–11–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 


jlentini on PROD1PC65 with NOTICES
52156 Federal Register / Vol. 72, No. 176 / Wednesday, September 12, 2007 / Notices 

Office of AIDS Research Advisory 

Council. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Office of AIDS 

Research Advisory Council. 

Date: October 24, 2007. 

Time: 9 AM to 5:30 PM. 

Agenda: The agenda will focus on the 

Prevention Research Challenges of HIV 

Infection in Racial and Ethnic Communities 

in the United States. An update will be 

provided on the OARAC Working Groups for 

Treatment and Prevention Guidelines. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

Contact Person: Christina Brackna, 

Coordinator, Program Planning and Analysis, 

Office of Aids Research, Office of the 

Director, NIH, 5635 Fishers Lane MSC 9310, 

Suite 4000, Rockville, MD 20852, (301) 402–

8655, cm53v@nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the 

Institute’s/Center’s home page: www.nih.gov/ 

od/oar/index.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4480 Filed 9–11–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Molecular 

Oncology P01. 

Date: October 2–3, 2007. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Michael B. Small, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8127, Bethesda, MD 

20892–8328, 301–402–0996, 

smallm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4481 Filed 9–11–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group, Clinical Trials 

Review Committee. 

Date: October 29–30, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Harbor Court 

Baltimore, 550 Light Street, Baltimore, MD 

21202. 

Contact Person: Patricia A. Haggerty, PhD, 

Section Chief, Clinical Studies and Training 

Scientific Review Group, Review Branch, 

Division of Extramural Research Activities, 

National Heart, Lung, and Blood Institute, 

NIH, 6701 Rockledge Drive, Room 7194, MSC 

7924, Bethesda, MD 20892, 301/435–0288, 

haggertp@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research, 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS.) 

Dated: September 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4479 Filed 9–11–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 


jlentini on PROD1PC65 with NOTICES